TFEX - Thailand Futures Exchange pcl

09/15/2026 | Press release | Distributed by Public on 09/15/2026 13:08

Report on the results of the Exercise of XBIO-W8 (F53-5) Revise (Revised) Facebook Line X Copy link

The results of the exercise of Warrants/TSR (F53-5) Report date of securities allocation : 14-Sep-2026 Exercised Securities Warrants Common shares Warrant of trading symbol : XBIO-W8 Name of warrant : Warrant of X BIOSCIENCE PUBLIC COMPANY LIMITED No. 8 Number of exercised warrants (units) : 10,000,000 Number of unexercised warrants : 222,349,082 (units) Ratio (Warrant : shares) : 1.00 : 2.55221 Exercise Price (baht/share) : 0.01567 Exercise Date (Update) : From 31-Aug-2026 to 31-Aug-2026 Number of shares derived from : 25,522,100 exercised warrants (shares) Number of remaining shares reserved : 567,481,189 (shares) Authorized to sign on behalf of the : Mr.Amnart Lertprasertwong company Position : Chief Executive Officer This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement. If you would like to see the full details of this information, please click view "full details" in attached file.
TFEX - Thailand Futures Exchange pcl published this content on September 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 15, 2026 at 19:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]